157 related articles for article (PubMed ID: 31755528)
1. Precision of Fetal DNA Fraction Estimation by Quantitative Polymerase Chain Reaction Quantification of a Differently Methylated Target in Noninvasive Prenatal Testing.
Blais J; Giroux S; Caron A; Clément V; Rousseau F
Lab Med; 2020 May; 51(3):279-287. PubMed ID: 31755528
[TBL] [Abstract][Full Text] [Related]
2. Total number of reads affects the accuracy of fetal fraction estimates in NIPT.
Miceikaitė I; Brasch-Andersen C; Fagerberg C; Larsen MJ
Mol Genet Genomic Med; 2021 Apr; 9(4):e1653. PubMed ID: 33687149
[TBL] [Abstract][Full Text] [Related]
3. Application of Differentially Methylated Loci in Clinical Diagnosis of Trisomy 21 Syndrome.
Zhang R; Yin Y; Zhang S; Chen L; Pu L; Deng Q; Zhang H; Xiao L
Genet Test Mol Biomarkers; 2019 Apr; 23(4):246-250. PubMed ID: 30986102
[TBL] [Abstract][Full Text] [Related]
4. Variability in Fetal Fraction Estimation: Comparing Fetal Fractions Reported by Noninvasive Prenatal Testing Providers Globally.
Becking EC; Linthorst J; Patton S; Gutowska-Ding W; Goodall R; Khawaja F; Morgan F; Deans Z; Chitty LS; Bekker MN; Scheffer PG; Sistermans EA
Clin Chem; 2023 Feb; 69(2):160-167. PubMed ID: 36576352
[TBL] [Abstract][Full Text] [Related]
5. Epigenome-wide DNA methylation assay reveals placental epigenetic markers for noninvasive fetal single-nucleotide polymorphism genotyping in maternal plasma.
Ou X; Wang H; Qu D; Chen Y; Gao J; Sun H
Transfusion; 2014 Oct; 54(10):2523-33. PubMed ID: 24749853
[TBL] [Abstract][Full Text] [Related]
6. FF-QuantSC: accurate quantification of fetal fraction by a neural network model.
Yuan Y; Chai X; Liu N; Gu B; Li S; Gao Y; Zhou L; Liu Q; Yang F; Liu J; Qiu J; Zhang J; Hou Y; Cen M; Tian Z; Tang W; Zhang H; Chen F; Yin Y; Wang W
Mol Genet Genomic Med; 2020 Jun; 8(6):e1232. PubMed ID: 32281746
[TBL] [Abstract][Full Text] [Related]
7. Development of a new methylation-based fetal fraction estimation assay using multiplex ddPCR.
Ioannides M; Achilleos A; Kyriakou S; Kypri E; Loizides C; Tsangaras K; Constantinou L; Koumbaris G; Patsalis PC
Mol Genet Genomic Med; 2020 Feb; 8(2):e1094. PubMed ID: 31821748
[TBL] [Abstract][Full Text] [Related]
8. Development of Reference Materials for Noninvasive Prenatal Aneuploidy Testing by Massively Parallel Sequencing: A Proof-of-Concept Study.
Blais J; Giroux S; Caron A; Clément V; Rousseau F
J Appl Lab Med; 2019 Jul; 4(1):50-60. PubMed ID: 31639707
[TBL] [Abstract][Full Text] [Related]
9. Variability of "Reported Fetal Fraction" in Noninvasive Prenatal Screening (NIPS).
Persson F; Prensky L
Clin Chem; 2021 Jun; 67(6):863-866. PubMed ID: 33734324
[TBL] [Abstract][Full Text] [Related]
10. Inferring fetal fractions from read heterozygosity empowers the noninvasive prenatal screening.
Dang M; Xu H; Zhang J; Wang W; Bai L; Fang N; Liang L; Zhang J; Liu F; Wu Q; Wang S; Guan Y
Genet Med; 2020 Feb; 22(2):301-308. PubMed ID: 31467446
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics Approaches for Fetal DNA Fraction Estimation in Noninvasive Prenatal Testing.
Peng XL; Jiang P
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230760
[TBL] [Abstract][Full Text] [Related]
12. Combining the use of a fetal fraction-based risk algorithm and probability of an informative redraw in noninvasive prenatal testing for fetal aneuploidy.
Benn P; Martin K; McKanna T; Valenti E; Billings P; Demko Z
J Genet Couns; 2020 Oct; 29(5):800-806. PubMed ID: 31872514
[TBL] [Abstract][Full Text] [Related]
13. Fetal fraction and noninvasive prenatal testing: What clinicians need to know.
Hui L; Bianchi DW
Prenat Diagn; 2020 Jan; 40(2):155-163. PubMed ID: 31821597
[TBL] [Abstract][Full Text] [Related]
14. High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening.
Welker NC; Lee AK; Kjolby RAS; Wan HY; Theilmann MR; Jeon D; Goldberg JD; Haas KR; Muzzey D; Chu CS
Genet Med; 2021 Mar; 23(3):443-450. PubMed ID: 33190143
[TBL] [Abstract][Full Text] [Related]
15. Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma.
van den Oever JM; Balkassmi S; Segboer T; Verweij EJ; van der Velden PA; Oepkes D; Bakker E; Boon EM
PLoS One; 2013; 8(12):e84051. PubMed ID: 24391879
[TBL] [Abstract][Full Text] [Related]
16. Multiplexed and Sensitive DNA Methylation Testing Using Methylation-Sensitive Restriction Enzymes "MSRE-qPCR".
Beikircher G; Pulverer W; Hofner M; Noehammer C; Weinhaeusel A
Methods Mol Biol; 2018; 1708():407-424. PubMed ID: 29224156
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive prenatal aneuploidy testing: Critical diagnostic performance parameters predict sample z-score values.
Blais J; Giroux S; Caron A; Clément V; Dionne-Laporte A; Jouan L; Gauthier J; MacLeod T; Moore R; Parker J; Swanson L; Zhao Y; Rouleau G; Karsan A; Langlois S; Rousseau F
Clin Biochem; 2018 Sep; 59():69-77. PubMed ID: 29958880
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.
Chan KC; Ding C; Gerovassili A; Yeung SW; Chiu RW; Leung TN; Lau TK; Chim SS; Chung GT; Nicolaides KH; Lo YM
Clin Chem; 2006 Dec; 52(12):2211-8. PubMed ID: 17068167
[TBL] [Abstract][Full Text] [Related]
19. Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21.
Lee DE; Lim JH; Kim MH; Park SY; Ryu HM
J Mol Diagn; 2016 May; 18(3):378-387. PubMed ID: 26947512
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of fetal DNA fraction in maternal plasma using circulating single molecule amplification and re-sequencing technology (cSMART).
Song Y; Zhou X; Huang S; Li X; Qi Q; Jiang Y; Liu Y; Ma C; Li Z; Xu M; Cram DS; Liu J
Clin Chim Acta; 2016 May; 456():151-156. PubMed ID: 26993877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
